MatrixCellect® 100 DBM Putty
Providing the next generation
of regenerative therapies.
Call us today at
(877) 887-3436
We are a distributor of amnion-derived products and other medical solutions to physicians, surgeons, clinics, and hospitals.
MatrixCellect® 100 DBM Putty
MatrixCellect® 100 is a 100% DBM putty processed using CellRight Technologies® proprietary demineralization process.
MatrixCellect® 100 has been histologically proven post sterilization to exhibit five elements of bone formation.
MatrixCellect® 100 does not contain any extrinsic carriers and is entirely derived from 100% allograft bone. MatrixCellect® 100 is provided in a ready to use syringe or jar.
MatrixCellect® 100 is provided with a medical device Sterility Assurance Level (SAL) 10-6. The product should be stored at room temperature (15˚C – 30˚C), and has a shelf life of two years from the date of packaging.
CellRight Technologies® employs strict quality assurance and
quality control procedures to ensure patient safety. CellRight’s medical director, a licensed physician, performs an extensive medical review of the donor’s medical/social history to determine eligibility. Only donors whose screening, serologic, and microbiologic tests meet or exceed the current standards established by the Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB) are accepted for transplantation.
MatrixCellect® 100 may be used in surgical procedures including:
- Spine
- Neuro
- Orthopedics
- Trauma
- Reconstruction
- Foot & Ankle
- Dental
Features and Benefits
- Osteoinductive – each lot is assayed
- Osteoconductive
- Sterile – Sterility Assurance Level (SAL) of 10-6
- Two year shelf-life
- 100% bone – no additional carrier
- Ambient storage and shipping temperatures
- Resists irrigation
- Available in syringe or jar
Call us today at
(877) 887-3436
REGENISOURCE PROVIDES THE NEXT GENERATION OF REGENERATIVE THERAPIES.
TESTIMONIALS
“My knee injections with amnio did exceptionally well for me, even letting me return in to competitive cycling. I put 1000 miles on my racing bike last year, only 6 months after my amnio injections.”
“In my 7 years using human placental tissue allografts patients experienced a more rapid recovery time than conventional standard of care treatments. Patients and I noted a significant decrease in inflammation/ swelling which reduces pain and increases function. Unlike cortisone which has a long list of side effects, no adverse events have ever been reported using these placental tissue allograft.”